Levofloksatsin (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Levofloksatsin" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

21nih.gov

4^th place

7^th place

18doi.org

2^nd place

3^rd place

4web.archive.org

1^st place

3drugs.com

399^th place

440^th place

3archive.org

6^th place

8^th place

3fda.gov

447^th place

745^th place

1t-pacient.ru

low place

1rmj.ru

9,799^th place

5,463^rd place

1rero.ch

3,510^th place

7,171^st place

1europa.eu

68^th place

50^th place

1cdc.gov

218^th place

199^th place

1cochranelibrary.com

low place

1,425^th place

1worldcat.org

5^th place

10^th place

archive.org

„Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders“. Pediatr. Infect. Dis. J. 26-jild, № 10. October 2007. 879–91-bet. doi:10.1097/INF.0b013e3180cbd382. PMID 17901792.
„In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin“. Antimicrob. Agents Chemother. 36-jild, № 4. April 1992. 860–6-bet. doi:10.1128/aac.36.4.860. PMC 189464. PMID 1503449.
„Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone“. Antimicrob. Agents Chemother. 41-jild, № 1. January 1997. 204–11-bet. doi:10.1128/AAC.41.1.204. PMC 163688. PMID 8980783.

cdc.gov

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

cochranelibrary.com

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

doi.org

„Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults“. Clin. Infect. Dis. 44 Suppl 2-jild. March 2007. S27–72-bet. doi:10.1086/511159. PMID 17278083.
File TM (August 2010). „Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines“. Clin. Infect. Dis. 51 Suppl 1-jild. S42–7-bet. doi:10.1086/653048. PMID 20597671.
„Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America“. Clin. Infect. Dis. 50-jild, № 5. March 2010. 625–63-bet. doi:10.1086/650482. PMID 20175247.
„Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America“. Clin. Infect. Dis. 50-jild, № 2. January 2010. 133–64-bet. doi:10.1086/649554. PMID 20034345.
„Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America“ (PDF). Clin. Infect. Dis. 56-jild, № 1. January 2013. 1–10-bet. doi:10.1093/cid/cis966. PMID 23230301. 2021-07-25da asl nusxadan (PDF) arxivlandi. Qaraldi: 2020-12-08.
Schaeffer AJ (September 2004). „NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis“. Int. J. Antimicrob. Agents. 24 Suppl 1-jild. S49–52-bet. doi:10.1016/j.ijantimicag.2004.02.009. PMID 15364307.
„Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery“. Cochrane Database Syst Rev. 2-jild. 2017. CD006364-bet. doi:10.1002/14651858.CD006364.pub3. PMC 5375161. PMID 28192644.
„Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis“. Pharm. Res. 35-jild, № 5. March 2018. 109-bet. doi:10.1007/s11095-018-2383-8. PMID 29582196.
„The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America“. Clin. Infect. Dis. 53-jild, № 7. 2011. e25–76-bet. doi:10.1093/cid/cir531. PMID 21880587.{{cite magazine}}: CS1 maint: date and year ()
„Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders“. Pediatr. Infect. Dis. J. 26-jild, № 10. October 2007. 879–91-bet. doi:10.1097/INF.0b013e3180cbd382. PMID 17901792.
„Fluoroquinolones in the management of community-acquired pneumonia in primary care“. Expert Rev Anti Infect Ther. 8-jild, № 11. November 2010. 1259–71-bet. doi:10.1586/eri.10.110. PMID 21073291.
„In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin“. Antimicrob. Agents Chemother. 36-jild, № 4. April 1992. 860–6-bet. doi:10.1128/aac.36.4.860. PMC 189464. PMID 1503449.
„Induction of resistance of Streptococcus pneumoniae to quinolones in vitro“. Chemotherapy. 39-jild, № 1. 1993. 36–9-bet. doi:10.1159/000238971. PMID 8383031.
Blondeau JM (May 1999). „A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'“. J. Antimicrob. Chemother. 43 Suppl B-jild, № 90002. 1–11-bet. doi:10.1093/jac/43.suppl_2.1. PMID 10382869.
„Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone“. Antimicrob. Agents Chemother. 41-jild, № 1. January 1997. 204–11-bet. doi:10.1128/AAC.41.1.204. PMC 163688. PMID 8980783.
John A. Bosso (1998). „New and Emerging Quinolone Antibiotics“. Journal of Infectious Disease Pharmacotherapy. 2-jild, № 4. 61–76-bet. doi:10.1300/J100v02n04_06. ISSN 1068-7777.
„Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin“. J Chemother. 6-jild, № 2. April 1994. 83–91-bet. doi:10.1080/1120009X.1994.11741134. PMID 8077990.
Hawkey, PM (May 2003). „Mechanisms of quinolone action and microbial response“. The Journal of Antimicrobial Chemotherapy. 51 Suppl 1-jild, № 90001. 29–35-bet. doi:10.1093/jac/dkg207. PMID 12702701.

drugs.com

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

europa.eu

ecdc.europa.eu

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

fda.gov

(10-iyul 2018-yil). „FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions“. Press-reliz. 26-dekabr 2020-yilda asl nusxadan arxivlandi. Qaraldi: 2020-yil 8-dekabr.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

accessdata.fda.gov

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

nih.gov

pubmed.ncbi.nlm.nih.gov

„Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults“. Clin. Infect. Dis. 44 Suppl 2-jild. March 2007. S27–72-bet. doi:10.1086/511159. PMID 17278083.
File TM (August 2010). „Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines“. Clin. Infect. Dis. 51 Suppl 1-jild. S42–7-bet. doi:10.1086/653048. PMID 20597671.
„Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America“. Clin. Infect. Dis. 50-jild, № 5. March 2010. 625–63-bet. doi:10.1086/650482. PMID 20175247.
„Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America“. Clin. Infect. Dis. 50-jild, № 2. January 2010. 133–64-bet. doi:10.1086/649554. PMID 20034345.
„Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America“ (PDF). Clin. Infect. Dis. 56-jild, № 1. January 2013. 1–10-bet. doi:10.1093/cid/cis966. PMID 23230301. 2021-07-25da asl nusxadan (PDF) arxivlandi. Qaraldi: 2020-12-08.
Schaeffer AJ (September 2004). „NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis“. Int. J. Antimicrob. Agents. 24 Suppl 1-jild. S49–52-bet. doi:10.1016/j.ijantimicag.2004.02.009. PMID 15364307.
„Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery“. Cochrane Database Syst Rev. 2-jild. 2017. CD006364-bet. doi:10.1002/14651858.CD006364.pub3. PMC 5375161. PMID 28192644.
„Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis“. Pharm. Res. 35-jild, № 5. March 2018. 109-bet. doi:10.1007/s11095-018-2383-8. PMID 29582196.
„The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America“. Clin. Infect. Dis. 53-jild, № 7. 2011. e25–76-bet. doi:10.1093/cid/cir531. PMID 21880587.{{cite magazine}}: CS1 maint: date and year ()
„Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders“. Pediatr. Infect. Dis. J. 26-jild, № 10. October 2007. 879–91-bet. doi:10.1097/INF.0b013e3180cbd382. PMID 17901792.
„Fluoroquinolones in the management of community-acquired pneumonia in primary care“. Expert Rev Anti Infect Ther. 8-jild, № 11. November 2010. 1259–71-bet. doi:10.1586/eri.10.110. PMID 21073291.
„In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin“. Antimicrob. Agents Chemother. 36-jild, № 4. April 1992. 860–6-bet. doi:10.1128/aac.36.4.860. PMC 189464. PMID 1503449.
„Induction of resistance of Streptococcus pneumoniae to quinolones in vitro“. Chemotherapy. 39-jild, № 1. 1993. 36–9-bet. doi:10.1159/000238971. PMID 8383031.
Blondeau JM (May 1999). „A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'“. J. Antimicrob. Chemother. 43 Suppl B-jild, № 90002. 1–11-bet. doi:10.1093/jac/43.suppl_2.1. PMID 10382869.
„Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone“. Antimicrob. Agents Chemother. 41-jild, № 1. January 1997. 204–11-bet. doi:10.1128/AAC.41.1.204. PMC 163688. PMID 8980783.
„Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin“. J Chemother. 6-jild, № 2. April 1994. 83–91-bet. doi:10.1080/1120009X.1994.11741134. PMID 8077990.
Hawkey, PM (May 2003). „Mechanisms of quinolone action and microbial response“. The Journal of Antimicrobial Chemotherapy. 51 Suppl 1-jild, № 90001. 29–35-bet. doi:10.1093/jac/dkg207. PMID 12702701.

ncbi.nlm.nih.gov

„Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery“. Cochrane Database Syst Rev. 2-jild. 2017. CD006364-bet. doi:10.1002/14651858.CD006364.pub3. PMC 5375161. PMID 28192644.
„In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin“. Antimicrob. Agents Chemother. 36-jild, № 4. April 1992. 860–6-bet. doi:10.1128/aac.36.4.860. PMC 189464. PMID 1503449.
„Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone“. Antimicrob. Agents Chemother. 41-jild, № 1. January 1997. 204–11-bet. doi:10.1128/AAC.41.1.204. PMC 163688. PMID 8980783.

toxnet.nlm.nih.gov

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

rero.ch

doc.rero.ch

„Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America“ (PDF). Clin. Infect. Dis. 56-jild, № 1. January 2013. 1–10-bet. doi:10.1093/cid/cis966. PMID 23230301. 2021-07-25da asl nusxadan (PDF) arxivlandi. Qaraldi: 2020-12-08.

rmj.ru

„arxiv nusxasi“. 2013-yil 26-yanvarda asl nusxadan arxivlangan. Qaraldi: 2022-yil 28-may.

t-pacient.ru

„arxiv nusxasi“. 2013-yil 22-mayda asl nusxadan arxivlangan. Qaraldi: 2022-yil 28-may.

web.archive.org

(10-iyul 2018-yil). „FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions“. Press-reliz. 26-dekabr 2020-yilda asl nusxadan arxivlandi. Qaraldi: 2020-yil 8-dekabr.
„arxiv nusxasi“. 2013-yil 22-mayda asl nusxadan arxivlangan. Qaraldi: 2022-yil 28-may.
„arxiv nusxasi“. 2013-yil 26-yanvarda asl nusxadan arxivlangan. Qaraldi: 2022-yil 28-may.
„Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America“ (PDF). Clin. Infect. Dis. 56-jild, № 1. January 2013. 1–10-bet. doi:10.1093/cid/cis966. PMID 23230301. 2021-07-25da asl nusxadan (PDF) arxivlandi. Qaraldi: 2020-12-08.

worldcat.org

John A. Bosso (1998). „New and Emerging Quinolone Antibiotics“. Journal of Infectious Disease Pharmacotherapy. 2-jild, № 4. 61–76-bet. doi:10.1300/J100v02n04_06. ISSN 1068-7777.